Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in metastatic RCC post-sunitinib
NCT01566747Phase 2Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Mar 2011
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pazopanib in renal cell carcinoma (RCC), sponsored by Cancer Trials Ireland. Started Mar 2011; status: completed.
02
Drugs
pazopanib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01566747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01566747.